IGENOMIX DEVELOPS THE FIRST MOLECULAR DIAGNOSTIC TOOL FOR CHRONIC ENDOMETRITIS, TO IMPROVE THE REPRODUCTIVE PROGNOSIS OF INFERTILE WOMEN